key: cord-0978273-bktoj8dl
authors: Hosseini, Javid; Pourani, Mohammadreza; Mehregan, Reihaneh; Forouzanfar, Mohammad‐Mehdi; Robati, Reza M
title: Frequency of COVID‐19 in acne patients treated with oral doxycycline: A retrospective cross‐sectional comparative study
date: 2021-08-20
journal: J Cosmet Dermatol
DOI: 10.1111/jocd.14403
sha: 2dd0f4ab710f4cb16ff3982b7e928f194e6c3008
doc_id: 978273
cord_uid: bktoj8dl

nan

To the Editor, Coronavirus disease 2019 (COVID-19) imposed a significant and notable burden of the disease on international health in the world. Many treatments have been proposed, and none of them have had an absolute efficacy against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. 1, 2 Doxycycline is a second-generation tetracycline antibiotic that, as an anti-inflammatory agent, might diminish the inflammatory process related to COVID-19. 1, 3 We designed a retrospective cross-sectional study and extracted the acne patients' electronic data treated with oral doxycycline 100 mg twice daily for more than three months and also another 

Ivermectin, famotidine, and doxycycline: A suggested combinatorial therapeutic for the treatment of COVID-19

Real estimates of mortality following COVID-19 infection

Doxycycline as potent inhibitor of covid-19 main protease: in-silico docking approach

Doxycycline treatment of high-risk COVID-19-positive patients with comorbid pulmonary disease

Clinical outcomes of early treatment with doxycycline for 89 high-risk COVID-19 patients in long-term care facilities in New York